MicroMass turns 25!
MicroMass Communications Inc., an Ashfield company, part of UDG Healthcare plc, has turned 25 and we would like to applaud all their success throughout the years.
Experts in Human Health Behaviour
MicroMass designs solutions across all therapeutic areas that improve patient and health outcomes by changing patient and provider behaviour. These solutions are customised to meet the individual needs of each MicroMass client. As the role of patients in healthcare decision making expands, coupled with the ongoing shift to digital channels, demand from pharmaceutical companies for behavioural change and direct patient engagement capabilities is increasing. MicroMass works with clients in the pharmaceutical and biotech industries to achieve commercial success in today’s value-based healthcare environment.
MicroMass has been recognised for their amazing, influential and current work throughout the industry with various industry recognition and award wins including: MM&M Top 100 Healthcare Agency, Eye for Pharma Most Valuable Patient Initiative finalist, Digital Health Award winner, eHealthcare Leadership Award winner, and DTC Perspectives winner.
This April saw the launch of a collaboration with MicroMass and MM&M with the release of their behavioural science eBook, Behavioral Science: The Key to Unlocking Better Outcomes. MicroMass co-sponsored this eBook and provided insights and quotes from five of their employees: Rob Peters, EVP, Strategy; Jessica Brueggeman, EVP, Health Behaviour Group; Meredith Terry, Lead Behaviourist, Innovation and Practice; Kathy Moriarty, Senior Behaviourist; and Andi Weiss, Lead Behaviourist, Partnerships and Advocacy. We wish MicroMass another successful 25 years as part of the Ashfield agency family.
Find out more about MicroMass here.